These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21707926)

  • 1. Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis.
    Fabre LF; Smith LC; DeRogatis LR
    J Sex Med; 2011 Sep; 8(9):2569-81. PubMed ID: 21707926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men.
    Fabre LF; Clayton AH; Smith LC; Goldstein I; Derogatis LR
    J Sex Med; 2012 Mar; 9(3):821-9. PubMed ID: 22240272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
    Fabre LF; Brown CS; Smith LC; Derogatis LR
    J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of major depression on sexual function in women.
    Fabre LF; Smith LC
    J Sex Med; 2012 Jan; 9(1):231-9. PubMed ID: 21883948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse prevention with gepirone ER in outpatients with major depression.
    Keller MB; Ruwe FJ; Janssens CJ; Sitsen JM; Jokinen R; Janczewski J
    J Clin Psychopharmacol; 2005 Feb; 25(1):79-84. PubMed ID: 15643103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D; Bridgman K; Buis C
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder.
    Revicki DA; Margolis MK; Fisher W; Rosen RC; Kuppermann M; Hanes V; Sand M
    J Sex Med; 2012 May; 9(5):1344-54. PubMed ID: 22376073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD
    Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Errata by Fabre et al. in gepirone-ER treatment of hypoactive sexual desire disorder associated with depression in women.
    Sand M
    J Sex Med; 2011 Oct; 8(10):2954. PubMed ID: 21967315
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.
    Wilcox CS; Ferguson JM; Dale JL; Heiser JF
    Psychopharmacol Bull; 1996; 32(3):335-42. PubMed ID: 8961776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Pyke RE; Clayton AH
    J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study.
    Bielski RJ; Cunningham L; Horrigan JP; Londborg PD; Smith WT; Weiss K
    J Clin Psychiatry; 2008 Apr; 69(4):571-7. PubMed ID: 18373383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women.
    Clayton AH; Maserejian NN; Connor MK; Huang L; Heiman JR; Rosen RC
    Psychosom Med; 2012 Apr; 74(3):305-11. PubMed ID: 22434918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.